Production of fructooligosaccharides by Bacillus subtilis natto CCT7712 and their antiproliferative potential

Aims Fructooligosaccharides (FOSs) known for their health properties and β‐(2→6)‐levan‐type FOSs have shown prebiotic and immunomodulatory activities that overcome those of commercial β‐(2→1)‐FOSs, but costs do not favour their use. Moreover, FOSs can reach the bloodstream through the diet, and litt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of applied microbiology 2020-05, Vol.128 (5), p.1414-1426
Hauptverfasser: Magri, A., Oliveira, M.R., Baldo, C., Tischer, C.A., Sartori, D., Mantovani, M.S., Celligoi, M.A.P.C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aims Fructooligosaccharides (FOSs) known for their health properties and β‐(2→6)‐levan‐type FOSs have shown prebiotic and immunomodulatory activities that overcome those of commercial β‐(2→1)‐FOSs, but costs do not favour their use. Moreover, FOSs can reach the bloodstream through the diet, and little is known about their direct effect on cells. The aim of this work was to produce high‐content FOSs by Bacillus subtilis natto CCT7712 in a bioreactor using commercial sucrose and to evaluate their antiproliferative effects in OVCAR‐3 cells. Methods and Results FOS production reached 173·60 g l−1, 0·2 vvm aeration and uncontrolled pH. Levan‐type FOSs, composed of β‐(2 → 6) links and mainly GF3 (6‐nystose), were identified using RMN spectroscopy, FT‐IR and ESI‐MS. FOSs decreased the viability and proliferation of OVCAR‐3 cells, and the effects were associated with an increased pro‐inflammatory response by the induction of IL‐8 and TNF‐α, and the repression of ER‐β genes. The metabolic profiles showed disruption of cellular homeostasis that can be associated with a decrease in proliferation. Conclusions The high production of levan‐type FOSs from B. subtilis natto CCT7712 in a bioreactor was achieved, and they showed antiproliferative potential in OVCAR‐3 cells. Significance and Impact of the Study FOS could be a good target for future therapeutic studies and commercial use.
ISSN:1364-5072
1365-2672
DOI:10.1111/jam.14569